MaxQ, a healthcare technology company that provides medical diagnostic AI applications and clinical workflow automation, announced the appointment of Eric Yablonka to its board of directors. Yablonka brings over 35 years of industry-leading healthcare technology experience to MaxQ, with a focus on advising and consulting companies, funds, and organizations on all matters relating to health information technologies, digital and business, and their applications.
“We are delighted to name one of the industry’s leading healthcare CIOs to our board of directors,” said MaxQ Chairman Ian Weingarten. “Eric brings vast experience to the company as one of the leaders in healthcare technology today. As a prominent advocate for healthcare innovation, we look forward to his guidance as we continue to expand MaxQ’s innovative product offerings.”
Yablonka previously served as CIO and Associate Dean at Stanford Medicine, developing and executing strategies that leverage technologies across patient care, medical research and teaching. Yablonka also previously served as vice president and CIO at UChicago Medicine for over 16 years, working alongside the Board of Trustees and leadership team to execute the business strategies of the organization.
Also Read: The proliferation of COVID-19 has reduces the M&A trends
Yablonka has a robust professional history working on behalf of leading health systems, as well as a variety of innovative healthcare technology companies.
“MaxQ’s mission to transform healthcare delivery to improve patient outcomes is inspiring and aligns with my professional interests and background as a digital leader in the healthcare technology space,” said Yablonka. “I look forward to partnering with the seasoned leadership team who are continuing to move the needle with innovation and use of cutting-edge AI solutions in healthcare.”
Yablonka has decades of experience advocating for innovation in the healthcare industry. He has been an early adopter of new medical and information technologies and frequently works with partners and new entrants to guide strategy, business planning and their value within the industry.
Yablonka’s industry-leading CIO experience will provide relatable and practical value to MaxQ as a board member, providing strategic guidance for the company’s continued expansion of clinical applications in healthcare artificial intelligence.
